Trinity Biotech plc (NASDAQ: TRIB) Stock Competitors & Peer Comparison
See TRIB's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for TRIB and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TRIB | $9.41 | -1.98% | 190.6M | -0.16 | -$60.60 | N/A |
| ALC | $70.50 | -2.19% | 34.4B | 22.17 | $3.18 | +0.51% |
| STE | $224.59 | -0.99% | 21.9B | 21.56 | $10.42 | +1.15% |
| QDEL | $13.97 | +0.29% | 952.6M | 10.43 | $1.34 | N/A |
| MLAB | $127.78 | -0.58% | 715M | 12.89 | $9.91 | +0.50% |
| BWAY | $14.15 | -2.48% | 555M | 35.95 | $0.39 | N/A |
| SI | $20.32 | -0.34% | 421.4M | -10.61 | -$1.91 | N/A |
| MASS | $10.05 | +0.10% | 412.3M | -16.75 | -$0.60 | N/A |
| MOBI | $11.63 | +0.00% | 386.7M | -0.62 | -$18.78 | N/A |
| ANIK | $20.81 | -0.90% | 278.5M | 42.47 | $0.49 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
TRIB vs ALC Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, ALC has a market cap of 34.4B. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while ALC trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas ALC's P/E ratio is 22.17. In terms of profitability, TRIB's ROE is +0.68%, compared to ALC's ROE of +0.03%. Regarding short-term risk, TRIB is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check ALC's competition here
STERIS plc (NYSE: STE)
TRIB vs STE Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, STE has a market cap of 21.9B. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while STE trades at $224.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas STE's P/E ratio is 21.56. In terms of profitability, TRIB's ROE is +0.68%, compared to STE's ROE of +0.11%. Regarding short-term risk, TRIB is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check STE's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
TRIB vs QDEL Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, QDEL has a market cap of 952.6M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while QDEL trades at $13.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas QDEL's P/E ratio is 10.43. In terms of profitability, TRIB's ROE is +0.68%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, TRIB is more volatile compared to QDEL. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check QDEL's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
TRIB vs MLAB Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, MLAB has a market cap of 715M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while MLAB trades at $127.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas MLAB's P/E ratio is 12.89. In terms of profitability, TRIB's ROE is +0.68%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, TRIB is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check MLAB's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
TRIB vs BWAY Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, BWAY has a market cap of 555M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while BWAY trades at $14.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas BWAY's P/E ratio is 35.95. In terms of profitability, TRIB's ROE is +0.68%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, TRIB is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check BWAY's competition here
Shoulder Innovations, Inc. (NYSE: SI)
TRIB vs SI Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, SI has a market cap of 421.4M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while SI trades at $20.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas SI's P/E ratio is -10.61. In terms of profitability, TRIB's ROE is +0.68%, compared to SI's ROE of -0.26%. Regarding short-term risk, TRIB is more volatile compared to SI. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check SI's competition here
908 Devices Inc. (NASDAQ: MASS)
TRIB vs MASS Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, MASS has a market cap of 412.3M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while MASS trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas MASS's P/E ratio is -16.75. In terms of profitability, TRIB's ROE is +0.68%, compared to MASS's ROE of -0.25%. Regarding short-term risk, TRIB is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check MASS's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
TRIB vs MOBI Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, MOBI has a market cap of 386.7M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while MOBI trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas MOBI's P/E ratio is -0.62. In terms of profitability, TRIB's ROE is +0.68%, compared to MOBI's ROE of -15.96%. Regarding short-term risk, TRIB is more volatile compared to MOBI. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check MOBI's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
TRIB vs ANIK Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, ANIK has a market cap of 278.5M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while ANIK trades at $20.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas ANIK's P/E ratio is 42.47. In terms of profitability, TRIB's ROE is +0.68%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, TRIB is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check ANIK's competition here
Standard BioTools Inc. (NASDAQ: LAB)
TRIB vs LAB Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, LAB has a market cap of 268.3M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while LAB trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas LAB's P/E ratio is -9.79. In terms of profitability, TRIB's ROE is +0.68%, compared to LAB's ROE of -0.18%. Regarding short-term risk, TRIB is more volatile compared to LAB. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check LAB's competition here
Edap Tms S.a. (NASDAQ: EDAP)
TRIB vs EDAP Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas EDAP's P/E ratio is -5.80. In terms of profitability, TRIB's ROE is +0.68%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, TRIB is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
TRIB vs NYXH Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, NYXH has a market cap of 162.1M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while NYXH trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas NYXH's P/E ratio is -0.64. In terms of profitability, TRIB's ROE is +0.68%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, TRIB is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check NYXH's competition here
Apyx Medical Corporation (NASDAQ: APYX)
TRIB vs APYX Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, APYX has a market cap of 128.4M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while APYX trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas APYX's P/E ratio is -15.25. In terms of profitability, TRIB's ROE is +0.68%, compared to APYX's ROE of -0.79%. Regarding short-term risk, TRIB is more volatile compared to APYX. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
TRIB vs SKIN Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, SKIN has a market cap of 88.8M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while SKIN trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas SKIN's P/E ratio is -3.11. In terms of profitability, TRIB's ROE is +0.68%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, TRIB is more volatile compared to SKIN. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check SKIN's competition here
DarioHealth Corp. (NASDAQ: DRIO)
TRIB vs DRIO Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, DRIO has a market cap of 52.9M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while DRIO trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas DRIO's P/E ratio is -1.24. In terms of profitability, TRIB's ROE is +0.68%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, TRIB is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check DRIO's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
TRIB vs MDAI Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, MDAI has a market cap of 50M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while MDAI trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas MDAI's P/E ratio is -3.49. In terms of profitability, TRIB's ROE is +0.68%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, TRIB is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check MDAI's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
TRIB vs BEAT Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, BEAT has a market cap of 23.7M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while BEAT trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas BEAT's P/E ratio is -0.84. In terms of profitability, TRIB's ROE is +0.68%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, TRIB is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check BEAT's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
TRIB vs BEATW Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, BEATW has a market cap of 8.4M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas BEATW's P/E ratio is -0.02. In terms of profitability, TRIB's ROE is +0.68%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, TRIB is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
TRIB vs WOK Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, WOK has a market cap of 5.1M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while WOK trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas WOK's P/E ratio is N/A. In terms of profitability, TRIB's ROE is +0.68%, compared to WOK's ROE of -0.19%. Regarding short-term risk, TRIB is more volatile compared to WOK. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
TRIB vs QTEXW Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, TRIB's ROE is +0.68%, compared to QTEXW's ROE of N/A. Regarding short-term risk, TRIB is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check QTEXW's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
TRIB vs FEED Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, FEED has a market cap of 3.1M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while FEED trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas FEED's P/E ratio is -0.03. In terms of profitability, TRIB's ROE is +0.68%, compared to FEED's ROE of -0.60%. Regarding short-term risk, TRIB is more volatile compared to FEED. This indicates higher risk in terms of short-term price fluctuations for TRIB.Check FEED's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
TRIB vs ITOC Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, ITOC has a market cap of 2.8M. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while ITOC trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas ITOC's P/E ratio is -0.95. In terms of profitability, TRIB's ROE is +0.68%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, TRIB is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check ITOC's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
TRIB vs TIVC Comparison September 2026
Trinity Biotech plc (NASDAQ: TRIB) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRIB stands at 190.6M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, TRIB is priced at $9.41 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRIB currently has a P/E ratio of -0.16, whereas TIVC's P/E ratio is -0.04. In terms of profitability, TRIB's ROE is +0.68%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, TRIB is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for TRIB.Check TIVC's competition here